Iris Acquisition Corp: Nasdaq/NYSE listing notice — Iris Acquisition Corp receives Nasdaq noncompliance notice for audit committee after director resignation

Iris Acquisition Corp

Resignation of Duriya Farooqui from Board on Dec 20, 2022 triggered audit committee deficiency under Nasdaq Rule 5605(c)(2)(A).
Audit Committee now has fewer than three independent members; Nasdaq provided cure period until next annual meeting or Dec 15, 2023.
If annual meeting before June 13, 2023, compliance must be shown by June 13, 2023.

item 3.01 item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Duriya Farooqui

Director

Iris Acquisition Corp

Filed: December 28, 2022, 6:59 PM ET

the previously disclosed resignation of Duriya Farooqui from the Company’s Board of Directors

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.82

Iris Acquisition Corp received a nasdaq noncompliance notice notice regarding other.

Exchange: nasdaq
Notice: noncompliance notice

Exact text from the filing

received a notice (the “Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) stating that the previously disclosed resignation of Duriya Farooqui from the Company’s Board of Directors (the “Board”) (as described in

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.9

Duriya Farooqui resigned as Director at Iris Acquisition Corp.

Action: resigned
Role: Director

Exact text from the filing

the previously disclosed resignation of Duriya Farooqui from the Company’s Board of Directors

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001104659-22-130563

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.